Link for free download of my 2 textbooks in high res PDF
http://159.69.48.3/
COVID-19 Vaccine Recommendations for Children and Teens
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccines-children-teens.html
What You Need to Know
CDC recommends everyone ages 5 years and older get vaccinated against COVID-19.
Everyone ages 5 years and older should also get a COVID-19 booster, when eligible.
Booster, at least 5 months after primary course
The Joint Committee on Vaccination and Immunisation (JCVI)
advise that all children aged 5 to 11 are offered the coronavirus (COVID-19) vaccine.
https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-covid-19-vaccination-for-children/coronavirus-covid-19-vaccine-for-children-aged-5-to-15/
https://www.nhsinform.scot/covid-19-vaccine/the-vaccines/vaccinating-children-aged-5-to-11-years
https://www.gov.uk/government/publications/jcvi-update-on-advice-for-covid-19-vaccination-of-children-aged-5-to-11/jcvi-statement-on-vaccination-of-children-aged-5-to-11-years-old
UK, 5 million age 5 to 11
Children aged 5 to 11 years will be offered 2 doses of the coronavirus vaccine.
JCVI advises a non-urgent offer of two 10 mcg doses of the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) to children aged 5 to 11 years of age who are not in a clinical risk group.
What about natural immunity
Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
https://www.cdc.gov/mmwr/volumes/71/wr/mm7117e3.htm?s_cid=mm7117e3_e&ACSTrackingID=USCDC_921-DM80513&ACSTrackingLabel=MMWR%20Early%20Release%20-%20Vol.%2071%2C%20April%2026%2C%202022&deliveryName=USCDC_921-DM80513
anti-N antibodies
As of February 2022, approximately 75% of children and adolescents had serologic evidence of previous infection with SARS-CoV-2, with approximately one third becoming newly seropositive since December 2021.
These findings illustrate a high infection rate for the Omicron variant, especially among children
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-biontech-covid-19-vaccine-demonstrates-strong-immune
UK, percentage of the population estimated to have antibodies was high for children in Great Britain
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/antibodies
Antibodies against SARS-CoV-2 at or above 179 nanograms per millilitre (ng/ml), UK, 29 November 2021 to 15 May 2022
Testing negative means that an individual did not have enough antibodies to be detected in the test, not that they do not have any immune protection against the virus.
Pfizer booster dose, the evidence
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-data-demonstrating-high-immune
Thursday, April 14, 2022
Data from a subanalysis of 30 sera
clinical trial of children 5 through 11 years
36-fold increase in SARS-CoV-2 Omicron neutralizing titers following a booster (third) dose
Phase 2/3 clinical trial with 140 children
a booster (third) dose increased neutralizing antibodies by 6-fold against the SARS-CoV-2 wild-type strain
Cost of Pfizer vaccine for 5 to 11 year olds
https://www.pharmaceutical-technology.com/analysis/covid-19-vaccine-pricing-varies-country-company/
EU, $23.15 per dose
US, $24
UK, x 5,000,000 = $115,750,000
Per primary course, = $231,500,000
With third dose, $347,250,000
£289,000,000
US, x 24,000,000 = $576,000,000
Per primary course, $1,152,000,000
With third dose, $1,728,000,000
Why America Doesn’t Trust the CDC
https://www.newsweek.com/why-america-doesnt-trust-cdc-opinion-1713145
MARTY MAKARY , PROFESSOR, JOHNS HOPKINS SCHOOL OF MEDICINE
Centers for Disease Control (CDC) vigorously recommended the booster for all 5 – 11
Pfizer spokesperson, it did not determine the efficacy of the booster in the 5-to-11-year-olds.
Advisory Committee on Immunization Practices (ACIP).
Eleven to one
Dr. Keipp Talbot, Vanderbilt University
vaccines, are not without their potential side effects
? sustainability of vaccinating the population every six months
Natural immunity
https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e1.htm
CDC data from New York and California demonstrated that natural immunity was 2.8 times more effective in preventing hospitalization
3.3 to 4.7 times more effective in preventing COVID infection compared to vaccination during the Delta wave.
Source